Ophthal-360

(Pending FDA Clearance)

Ophthal-360 is an AI technology for autonomous detection of Diabetic Retinopathy (DR), enabling efficient and fast screenings for signs of Diabetic Retinopathy in both clinical and retail settings.

Before you continue reading about the Ophthal-360, it would be a great idea to familiarize yourself with Diabetic Retinopathy. Read more further below.

Who to screen?

Anyone with any diabetes can get diabetic retinopathy, including type 1, type 2, and gestational diabetes (diabetes that can develop during pregnancy). However, since diabetes is a chronic and slowly progressive disease, up to 60% of diabetic patients are not aware of their condition. Therefore, it may be a good idea to screen all diabetic patients for DR.

Ophthal-360 Real-time Quality Assessment

Ophthal-360 verifies the quality of submitted photos in real-time to ensure they can be read.

Diabetic Retinopathy Severity Grading

Want to try ophthal-360?

Ophthal-360 can be integrated with your clinical workflow to enable automated DR screening.

Cost-efficient and time-saving

Ophthal-360 reduces the time spent examining healthy patients by enabling lightly trained medical personnel to pre-screen all diabetic patients.

Easy to use

A simple system has been developed to be easy to use and learn for clinicians and non-clinicians.

fasT

Instant results on automated screening for signs of Diabetic Retinopathy less than 10 seconds.



Secure

Our systems' encrypted data storage and communication ensure that all data is 100 % secure.

Frequently asked questions

Ophthal-360 is an AI-based technology that autonomously detects mild to moderate (mtmDR) and vision-threatening diabetic retinopathy (vtDR) in the eyes of adults diagnosed with diabetes mellitus and who have not been previously diagnosed. The purpose of the Ophthal-360 is to make it accessible to perform and receive diabetic retinopathy screenings.

The Ophthal-360 system autonomously analyzes a patient’s retinal images taken using a fundus camera, robustly detects lesions, and delivers a report in under 10 seconds on the same day.

 

 

The Ophthal-360 AI eye screening is primarily cloud-based and installed on most Windows PCs with internet access. Therefore, no additional software is required.

Please get in touch  for pricing information.